openPR Logo
Press release

Unveiling Tegoprazan Impurity 2: A Critical Reference Standard in P-CAB Drug Development

07-17-2025 05:21 PM CET | Health & Medicine

Press release from: Aquigen Bio Sciences

Unveiling Tegoprazan Impurity 2: A Critical Reference Standard

As the pharmaceutical industry advances toward next-generation acid suppression therapies, potassium-competitive acid blockers (P-CABs) like Tegoprazan are emerging as game changers in the treatment of gastroesophageal reflux disease (GERD) and other acid-related conditions. However, to ensure the safety, efficacy, and regulatory compliance of P-CAB-based drugs, identifying and monitoring impurities during synthesis and storage is non-negotiable.

Explore Tegoprazan Category
https://aquigenbio.com/products/impurity-standards/tegoprazan/

One such critical impurity is Tegoprazan Impurity 2 - a process-related compound now available as a high-purity analytical reference standard through AquigenBio. Designed to support method development, regulatory filings, and quality assurance workflows, this impurity standard plays a pivotal role in maintaining pharmaceutical excellence throughout the lifecycle of tegoprazan-based formulations.

What Is Tegoprazan Impurity 2?

Tegoprazan Impurity 2 is a chemically distinct byproduct or intermediate that can arise during the multi-step synthesis of the API tegoprazan. While not therapeutically active, such impurities are essential to monitor in accordance with ICH Q3A/B guidelines and regulatory expectations from agencies like the FDA and EMA.

Offered by AquigenBio, this impurity is manufactured with a high level of purity and structural confirmation, including NMR, LC-MS, IR, and UV analysis. It comes with full documentation for analytical laboratories and formulation teams.
Key Product Overview: Tegoprazan Impurity 2
Product Link: https://aquigenbio.com/product/tegoprazan-impurity-2/

Product Name: Tegoprazan Impurity 2

CAS Number: 1640981-02-7
Molecular Formula: C18H20N2O4
Molecular Weight: 328.36 g/mol
Physical Form: Off-white to pale yellow solid
Purity: ≥ 95% (HPLC and NMR validated)

Applications:
Analytical method development
Routine quality control
Regulatory submissions
Stability and degradation studies

Documentation Provided:
Certificate of Analysis (CoA)
Safety Data Sheet (SDS)

Spectroscopic data (NMR, IR, MS)
Storage Conditions: 2-8°C, dry and away from light

Packaging: Customizable (mg to gram scale)

Availability: Global shipping with fast dispatch

Why Impurities Like Tegoprazan Impurity 2 Matter
Pharmaceutical impurities can arise from various sources including synthesis steps, raw materials, degradation, and storage. Regulatory agencies globally mandate the identification, qualification, and quantification of these impurities to safeguard human health.

Specifically, Tegoprazan Impurity 2 allows manufacturers and analytical teams to:
Ensure API consistency from batch to batch.

Avoid toxicological risk from unknown contaminants.

Align with ICH Q3A/B and M7 guidelines.

Maintain high analytical precision and regulatory readiness.

AquigenBio: A Global Provider of Impurity Standards
AquigenBio specializes in the synthesis and supply of high-quality impurity reference standards, including those related to emerging APIs like tegoprazan.

Their expertise spans across:
Impurity synthesis and characterization
Custom synthesis and scale-up
Deuterated compounds and nitrosamine standards
Rapid international delivery and documentation support

With a robust R&D backbone and customer-focused service, AquigenBio is a preferred partner for pharmaceutical QC labs, CROs, and formulators worldwide.
Related Products in the Tegoprazan Impurity Series
AquigenBio also offers other critical impurities in the tegoprazan impurity profile, helping clients cover all analytical bases.

Tegoprazan Nitroso Impurity 2
Product Link: https://aquigenbio.com/product/tegoprazan-nitroso-impurity-2/

Nitroso impurities, classified as genotoxic and potentially carcinogenic, have been a significant focus of recent regulatory alerts. Even at trace levels, these compounds must be identified and quantified during development and shelf-life studies.

Use Case:
Supports ICH M7 (R1) risk assessments
Used in nitrosamine control strategies
Purity: ≥ 95%
Ideal for:
LC-MS/MS method validation
Impurity profiling in final formulations
Documentation Provided:
CoA
SDS
Mass spec and NMR data
Storage: Store cold and protected from light

Tegoprazan Impurity 1
Product Link: https://aquigenbio.com/product/tegoprazan-impurity-1/

This compound is one of the primary process-related impurities in tegoprazan synthesis and is required for complete impurity profiling in any regulatory dossier.
Product Name: Tegoprazan Impurity 1
Purity: ≥ 95% (HPLC and NMR tested)

Structure Confirmed By:
LC-MS
NMR
IR

Applications:
Analytical method validation
Stress testing
Long-term stability studies
Documentation Provided: CoA, SDS, full analytical package
Storage Conditions: 2-8°C

Availability: Global delivery from AquigenBio warehouse

Analytical and Regulatory Benefits
Incorporating certified reference impurities like Tegoprazan Impurity 2 in your analytical program ensures:

Improved chromatographic selectivity
Robust method validation results
Easier preparation of regulatory filings (DMF, ANDA, NDA)
Confident quantification of known and unknown impurities
Greater reproducibility in stress and forced degradation studies

Whether you're preparing for a pre-approval inspection or simply strengthening your internal quality systems, these impurity standards provide the clarity and control your lab needs.

Custom Synthesis and Technical Support

Custom synthesis of novel or unknown impurities
Isotopically labeled standards (D, 13C)
Toxicological qualification support

Documentation tailored for IND/ANDA/NDA filings

Their expert team can synthesize milligram to kilogram quantities with full characterization.

Safety, Handling, and Storage
All impurity standards from AquigenBio come with full safety documentation. Key recommendations include:
Handle inside a fume hood
Wear gloves, goggles, and lab coat
Store at recommended temperature (usually 2-8°C)
Avoid moisture and direct sunlight exposure

Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com

About Aquigen Bio
AquigenBio is a leading life sciences company specializing in the synthesis, development, and global distribution of pharmaceutical impurity reference standards. Headquartered in Pune, India, with international reach, AquigenBio supports pharmaceutical manufacturers, CROs, and research institutions in ensuring regulatory compliance, analytical accuracy, and quality assurance throughout the drug development lifecycle.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Unveiling Tegoprazan Impurity 2: A Critical Reference Standard in P-CAB Drug Development here

News-ID: 4108245 • Views:

More Releases from Aquigen Bio Sciences

Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Development, Quality Control, and Regulatory Compliance in Pharmaceutical Research
Estradiol Valerate EP Impurity A - Premium Reference Standard for Analytical Dev …
Estradiol Valerate EP Impurity A is a high-quality reference standard designed to meet the stringent requirements of pharmaceutical research, method validation, and quality control processes. Explore Estradiol Valerate EP Impurity A : https://aquigenbio.com/product/estradiol-valerate-ep-impurity-a/ Manufactured and characterized with precision, this impurity standard supports laboratories and manufacturers in achieving consistent, reliable, and reproducible results in critical analytical workflows. With its exceptional purity and accurate characterization, Estradiol Valerate EP Impurity A plays a vital role
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deuterated Nitrosamine Impurity Standard for Method Development, Validation, Quality Control, and Regulatory Submissions in Betahistine Impurity Profiling and Research
High-Purity N-Nitroso Betahistine D3 for Precise Pharmaceutical Analysis | Deute …
Product Overview N-Nitroso Betahistine D3 is a premium deuterated nitrosamine impurity standard, specifically developed for precise analytical testing in pharmaceutical laboratories. This reference standard is widely used for analytical method development, validation, and quality control processes to meet stringent regulatory guidelines. With exceptional purity, complete documentation, and reliable traceability, it is ideal for research, development, and compliance applications. https://aquigenbio.com/product/n-nitroso-betahistine-d3/ Key Features and Benefits Deuterated Design for Precision: The incorporation of deuterium improves mass spectrometric
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impurity Standards
Aquigen Bio Strengthens Pharmaceutical Research with High-Purity Icatibant Impur …
Aquigen Bio, a trusted supplier of pharmaceutical reference standards, today announced the expansion of its Icatibant Impurity Standards portfolio, designed to support drug developers, analytical laboratories, and research organizations with reliable materials for impurity profiling and quality control. Icatibant, a selective bradykinin B2 receptor antagonist, is widely used in the treatment of hereditary angioedema (HAE). Given its peptide-based structure, Icatibant is prone to the formation of impurities during synthesis and storage.
Elevating Analytical Precision with Harmine Impurity Standards
Elevating Analytical Precision with Harmine Impurity Standards
In the realm of pharmaceutical research, controlling the purity of compounds is pivotal. When evaluating psychoactive alkaloids such as harmine-a β-carboline alkaloid known for its reversible monoamine oxidase A inhibition and emerging therapeutic potential-accuracy is non-negotiable. This is where Aquigen Bio Sciences brings its edge: supplying high-grade impurity standards to underpin analytical consistency and regulatory compliance. Why Harmine Impurity Standards Matter https://aquigenbio.com/products/impurity-standards/harmine/ Harmine occurs naturally in Peganum harmala and Banisteriopsis caapi, and has

All 5 Releases


More Releases for Impurity

Tizanidine Nitroso Impurity 1 - High-Purity Reference Standard for Reliable Impu …
In the highly regulated world of pharmaceutical manufacturing, impurity profiling plays a critical role in ensuring drug safety, efficacy, and regulatory compliance. Among the wide range of impurity reference standards required during API development and validation, Tizanidine Nitroso Impurity 1 stands out as a vital compound for researchers and manufacturers working on Tizanidine-based formulations. At Aquigen Bio, we are proud to offer Tizanidine Nitroso Impurity 1, a high-purity reference standard meticulously
AquigenBio Launches High-Purity EP Impurity Standards for Propylthiouracil, Incl …
AquigenBio is pleased to announce the availability of two essential impurity reference standards-Propylthiouracil EP Impurity A and Propylthiouracil EP Impurity B. These impurity standards are now available to support pharmaceutical companies, contract research organizations, and analytical laboratories engaged in drug development, quality control, and regulatory compliance. Propylthiouracil (PTU) is a well-known antithyroid medication, widely used in the treatment of hyperthyroidism. In line with pharmacopeial guidelines, it is critical to identify and
Precision in Impurity Profiling: Aquigen Bio Introduces High-Purity Doxorubicin …
Pune, India - July 2025 - As regulatory standards tighten across the pharmaceutical industry, the need for accurate, high-purity reference standards has never been more critical. Aquigen Bio, a trusted provider of pharmaceutical reference materials, is proud to announce the availability of Doxorubicin Dimer Impurity 3, a key impurity used in the impurity profiling of the widely used chemotherapeutic agent, Doxorubicin. This launch is part of Aquigen Bio's expanded portfolio of
Breaking Ground in Pharmaceutical Impurity Standards: Aquigen Bio Expands Abirat …
In the evolving landscape of pharmaceutical development and quality control, the identification, synthesis, and supply of high-purity impurity standards play a pivotal role. One of the most significant advancements in recent times is the availability of specialized Abiraterone-related impurity standards-essential tools for characterizing drug formulations and ensuring regulatory compliance. Manufactured and supplied by Aquigen BioSciences, a trusted leader in impurity synthesis and reference standards, these impurity standards offer analytical laboratories and
Unlock Advanced Dabigatran Research with High-Purity Standards: Now Available - …
In the ever-evolving pharmaceutical landscape, precision, safety, and regulatory compliance have never been more crucial. With Dabigatran etexilate mesylate becoming a cornerstone in the management of thromboembolic disorders, the demand for high-purity standards and robust impurity profiling has surged. Recognizing this essential need, a new suite of advanced analytical tools for Dabigatran and its associated impurities has been made available to support the global scientific and quality control community. To kno
Aquigen Bio Expands Oncology Impurity Standards Portfolio with High-Purity Etopo …
India - 07/05/2025 - Aquigen Bio, a leading provider of pharmaceutical impurity reference standards, proudly announces the launch of its latest high-quality product: Etoposide EP Impurity A. This new addition to Aquigen's growing portfolio of oncology-related impurities is tailored to meet the stringent requirements of pharmaceutical manufacturers and analytical laboratories focused on drug safety, efficacy, and compliance. To know more about : Etoposide EP Impurity A https://aquigenbio.com/product/etoposide-ep-impurity-a/ A Strategic Addition to Oncology Drug